Pulse Cyclophosphamide Decreases Sympathetic Postganglionic Activity, Controls Alveolitis, and Normalizes Vascular Tone Dysfunction (Raynaud's Phenomenon) in a Case of Early Systemic Sclerosis

Arthritis Care & Research
doi 10.1002/art.20542
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Infusion of Iloprost, a Prostacyclin Analogue, for Treatment of Raynaud's Phenomenon in Systemic Sclerosis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1988English

Prostaglandins I2 and E1 and Red Cell Deformability in Raynaud's Phenomenon and Systemic Sclerosis

BMJ
1981English

Effect of Prostaglandins I2 and E1 on Red Cell Deformability in Patients With Raynaud's Phenomenon and Systemic Sclerosis.

BMJ
1981English

Raynaud's Phenomenon

Nurse Prescribing
2017English

NGF-independent Survival of Postganglionic Sympathetic Neurons in Neuronal-Vascular Smooth Muscle Cocultures

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2001English

Artifactual Hypoglycaemia in Systemic Sclerosis and Raynaud’s Phenomenon: A Clinical Case Report and Short Review

Case Reports in Endocrinology
EndocrinologyMetabolismDiabetes
2016English

A Woman With Dysphagia and Raynaud's Phenomenon

Postgraduate Medical Journal
Medicine
2002English

Autohaemagglutination and Raynaud's Phenomenon

BMJ
1947English

Raynaud's Phenomenon in Pediatric Age

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy